Cannabis in Brazil:
The Collegiate Board Resolutions RDC No. 1,011/2026, RDC No. 1,012/2026, RDC No. 1,013/2026, RDC No. 1,014/2026, and RDC No. 1,015/2026 were published in the Official Gazette of the Union.
The new resolutions establish a new benchmark for the sanitary regulatory framework of Cannabis sativa and its derivatives in the country.
These regulations represent a relevant advancement in the consolidation of the Brazilian regulatory framework applicable to medicinal cannabis.
The set of these RDCs establishes clear guidelines for scientific research and technological development.
It also defines parameters for the production, importation, distribution, and medicinal use of cannabis, always under rigorous sanitary surveillance.
In this context, the regulatory movement remains aligned with international best practices.
Thus, it seeks to balance therapeutic access, the protection of public health, and regulatory predictability for economic agents.
As a result, the impacts of these resolutions are direct and relevant for companies, patient associations, and researchers.
Likewise, they affect educational institutions and other organizations interested in this segment.
For this reason, the correct interpretation of the provisions becomes essential.
In addition, understanding the terms of validity and the interactions with other sanitary regulations reduces regulatory and operational risks.
In parallel, the new regulatory scenario requires strategic planning and documentary compliance.
It also demands the review of internal processes, especially for organizations seeking sanitary authorization or expansion in the Brazilian medicinal cannabis market.
The ELS Group continuously monitors these regulatory updates and analyzes their practical effects. In this way, it anticipates relevant impacts for the sector.
Our work prioritizes risk mitigation and regulatory security. Thus, we provide strategic technical support for decisions aligned with the current requirements.
Finally, in case of questions or interest in evaluating the impacts of these RDCs on your business model or institutional project, please contact us. We are available to provide technical, safe, and strategic guidance.
Related content:
Exploring the market and regulatory opportunities of medicinal cannabis in Brazil – ELS Podcast
The expansion of the cannabis market in Europe – ELS Podcast
The evolution of medicinal cannabis in Portugal – ELS Board Talks
